DrugPatentWatch Database Preview
Shire Human Genetic Company Profile
» See Plans and Pricing
US Patents for Shire Human Genetic
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire Human Genetic | VPRIV | velaglucerase alfa | POWDER;INTRAVENOUS | 022575 | 002 | 2010-02-26 | 9,987,416 | 2039-02-26 | DISCN | Orphan | search | |
Shire Human Genetic | VPRIV | velaglucerase alfa | POWDER;INTRAVENOUS | 022575 | 002 | 2010-02-26 | 9,775,946 | 2039-02-26 | DISCN | Orphan | search | |
Shire Human Genetic | VPRIV | velaglucerase alfa | POWDER;INTRAVENOUS | 022575 | 002 | 2010-02-26 | 10,760,112 | Shire Human Genetic Therapies, Inc. (Lexington, MA) | 2034-12-18 | DISCN | Orphan | search |
Shire Human Genetic | VPRIV | velaglucerase alfa | POWDER;INTRAVENOUS | 022575 | 002 | 2010-02-26 | 10,675,328 | Children\'s Hospital Medical Center (Cincinnati, OH) | 2037-02-14 | DISCN | Orphan | search |
Shire Human Genetic | VPRIV | velaglucerase alfa | POWDER;INTRAVENOUS | 022575 | 002 | 2010-02-26 | 10,668,053 | Selecta Biosciences, Inc. (Watertown, MA) | 2033-05-03 | DISCN | Orphan | search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |